Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Gastric Cancer

Free Subscription Articles published in Int J Cancer Retrieve available abstracts of 30 articles: HTML format

Single Articles

August 2025
1. MA S, Zhang Y, Xie S, Li X, et al
   Balanced diet quality and risk of upper gastrointestinal cancers: Insights from a prospective cohort study in China.
   Int J Cancer. 2025;157:658-671.
   PubMed     Abstract available
   
   
   July 2025
2. LIU Y, Xue Q, Wang B, Ding X, et al
   Conversion therapy with sintilimab combined with chemotherapy and apatinib in stage IV gastric cancer.
   Int J Cancer. 2025 Jul 2. doi: 10.1002/ijc.35511.
   PubMed     Abstract available
   
   
   June 2025
3. GEERTS JFM, Vissers PAJ, Mostert B, Wijnhoven BPL, et al
   Hospital variation in treatment for synchronous metastatic esophageal and gastric cancer: A nationwide population-based study in the Netherlands.
   Int J Cancer. 2025 Jun 5. doi: 10.1002/ijc.35491.
   PubMed     Abstract available
   
   
   
4. CHAN WC, Millwood I, Kartsonaki C, Du H, et al
   Adiposity and risks of gastrointestinal cancers: A 10-year prospective study of 0.5 million Chinese adults.
   Int J Cancer. 2025;156:2094-2106.
   PubMed     Abstract available
   
   
   May 2025
5. PELC Z, Sedlak K, Mlak R, Endo Y, et al
   Impact of prognostic nutritional index on oncological outcomes and mortality among advanced gastric cancer patients: European GASTRODATA registry analysis.
   Int J Cancer. 2025 May 28. doi: 10.1002/ijc.35489.
   PubMed     Abstract available
   
   
   March 2025
6. JIANG XW, Zhang L, Liu ZC, Zhou T, et al
   Integrative metabolomics and microbiomics analysis reveals distinctive microbiota-metabolites interactions in gastric carcinogenesis.
   Int J Cancer. 2025 Mar 10. doi: 10.1002/ijc.35392.
   PubMed     Abstract available
   
   
   
7. ENGLISH KA, Goldsworthy M, Willis B, Kooblall KG, et al
   Calcium sensing receptor expression is downregulated in gastroenteropancreatic neuroendocrine tumours via epigenetic mechanisms.
   Int J Cancer. 2025;156:980-992.
   PubMed     Abstract available
   
   
   January 2025
8. SLOTMAN E, Pape M, van Laarhoven HWM, Pouw RE, et al
   Considerations to forgo systemic treatment in patients with advanced esophageal or gastric cancer: A real-world evidence study.
   Int J Cancer. 2025 Jan 9. doi: 10.1002/ijc.35314.
   PubMed     Abstract available
   
   
   December 2024
9. SEWASTJANOW-SILVA M, Kwiatkowski E, Yamashita K, Abdelhakeem A, et al
   Three biomarkers (HER2, PD-L1, and microsatellite status) in a large cohort of metastatic gastroesophageal adenocarcinomas: The MD Anderson Cancer Center experience.
   Int J Cancer. 2024;155:2277-2286.
   PubMed     Abstract available
   
   
   
10. INOUE-CHOI M, Freedman ND, Etemadi A, Hashemian M, et al
    One-carbon metabolism biomarkers and upper gastrointestinal cancer in the Golestan Cohort Study.
    Int J Cancer. 2024;155:1944-1957.
    PubMed     Abstract available
    
    
    October 2024
11. YAN X, Zeng H, Li H, Cao M, et al
    The current infection with Helicobacter pylori and association with upper gastrointestinal lesions and risk of upper gastrointestinal cancer: Insights from multicenter population-based cohort study.
    Int J Cancer. 2024;155:1203-1211.
    PubMed     Abstract available
    
    
    August 2024
12. LIU J, Gan T, Hu W, Li Y, et al
    Does ambient particulate matter 1 increase the risk of gastric cancer in the northwest of China?
    Int J Cancer. 2024 Aug 23. doi: 10.1002/ijc.35144.
    PubMed     Abstract available
    
    
    July 2024
13. WANG R, Chen XZ
    Comment on "Infectious pathogens and risk of esophageal, gastric and duodenal cancers and ulcers in China: A case-cohort study".
    Int J Cancer. 2024;155:184-185.
    PubMed    
    
    
    June 2024
14. MASETTI M, Al-Batran SE, Goetze TO, Thuss-Patience P, et al
    Efficacy of ramucirumab combination chemotherapy as second-line treatment in patients with advanced adenocarcinoma of the stomach or gastroesophageal junction after exposure to checkpoint inhibitors and chemotherapy as first-line therapy.
    Int J Cancer. 2024;154:2142-2150.
    PubMed     Abstract available
    
    
    
15. NAGEL G, Chen J, Jaensch A, Skodda L, et al
    Long-term exposure to air pollution and incidence of gastric and the upper aerodigestive tract cancers in a pooled European cohort: The ELAPSE project.
    Int J Cancer. 2024;154:1900-1910.
    PubMed     Abstract available
    
    
    May 2024
16. GONZALEZ-PALACIOS S, Compan-Gabucio LM, Torres-Collado L, Oncina-Canovas A, et al
    The protective effect of dietary folate intake on gastric cancer is modified by alcohol consumption: A pooled analysis of the StoP Consortium.
    Int J Cancer. 2024 May 16. doi: 10.1002/ijc.35004.
    PubMed     Abstract available
    
    
    December 2023
17. SASAHARA M, Kanda M, Tanaka C, Shimizu D, et al
    Therapeutic antibody targeting natriuretic peptide receptor 1 inhibits gastric cancer growth via BCL-2-mediated intrinsic apoptosis.
    Int J Cancer. 2023 Dec 27. doi: 10.1002/ijc.34831.
    PubMed     Abstract available
    
    
    
18. ZHANG Q, Zhou Y, Song L, Fang W, et al
    China special issue on gastrointestinal tumors-Improved survival after multidisciplinary team decision for patients with advanced gastrointestinal cancer: A multicenter, noninterventional, controlled study.
    Int J Cancer. 2023;153:1885-1893.
    PubMed     Abstract available
    
    
    November 2023
19. GOETZE TO, Stein A, Lorenzen S, Habibzada T, et al
    Ramucirumab beyond progression plus TAS-102 in patients with advanced or metastatic esophagogastric adenocarcinoma, after treatment failure on a ramucirumab-based therapy.
    Int J Cancer. 2023;153:1726-1733.
    PubMed     Abstract available
    
    
    
20. RIJKEN A, Pape M, Simkens GA, de Hingh IHJT, et al
    Peritoneal metastases from gastric cancer in a nationwide cohort: Incidence, treatment and survival.
    Int J Cancer. 2023 Nov 2. doi: 10.1002/ijc.34780.
    PubMed     Abstract available
    
    
    October 2023
21. FAN XH, Zhang Y, Wang P, Song QQ, et al
    A noninvasive multianalytical approach establishment for risk assessment and gastric cancer screening.
    Int J Cancer. 2023 Oct 16. doi: 10.1002/ijc.34739.
    PubMed     Abstract available
    
    
    September 2023
22. LLACH J, Salces I, Guerra A, Penas B, et al
    Endoscopic surveillance for familial intestinal gastric cancer in low-incidence areas: An effective strategy.
    Int J Cancer. 2023 Sep 7. doi: 10.1002/ijc.34714.
    PubMed     Abstract available
    
    
    
23. PALOMAR-CROS A, Straif K, Romaguera D, Aragones N, et al
    Consumption of aspartame and other artificial sweeteners and risk of cancer in the Spanish multicase-control study (MCC-Spain).
    Int J Cancer. 2023;153:979-993.
    PubMed     Abstract available
    
    
    August 2023
24. CHENG L, Chang Y, Xia Z, Liu Y, et al
    Remote modulation of WWOX by an intronic variant associated with survival of Chinese gastric cancer patients.
    Int J Cancer. 2023 Aug 24. doi: 10.1002/ijc.34703.
    PubMed     Abstract available
    
    
    
25. CAO F, Sun H, Yang Z, Bai Y, et al
    Multiple approaches revealed MGc80-3 as a somatic hybrid with HeLa cells rather than a gastric cancer cell line.
    Int J Cancer. 2023 Aug 6. doi: 10.1002/ijc.34677.
    PubMed     Abstract available
    
    
    July 2023
26. GOETZE TO, Hofheinz RD, Gaiser T, Schmalenberg H, et al
    Perioperative FLOT plus ramucirumab for resectable esophagogastric adenocarcinoma: A randomized phase II/III trial of the German AIO and Italian GOIM.
    Int J Cancer. 2023;153:153-163.
    PubMed     Abstract available
    
    
    March 2023
27. GHASEMI-KEBRIA F, Semnani S, Fazel A, Etemadi A, et al
    Esophageal and gastric cancer incidence trends in Golestan, Iran: an age-period-cohort analysis 2004-2018.
    Int J Cancer. 2023 Mar 21. doi: 10.1002/ijc.34518.
    PubMed     Abstract available
    
    
    
28. MOHRING C, Manczak A, Timotheou A, Sadeghlar F, et al
    Perioperative Therapy with Flot4 Significantly Increases Survival in Patients with Gastroesophageal and Gastric Cancer in A Large Real-World Cohort.
    Int J Cancer. 2023 Mar 15. doi: 10.1002/ijc.34511.
    PubMed     Abstract available
    
    
    
29. KUIJPER SC, Pape M, Vissers PAJ, Jeene PM, et al
    Trends in best-case, typical and worst-case survival scenarios of patients with non-metastatic esophagogastric cancer between 2006 and 2020: a population-based study.
    Int J Cancer. 2023 Mar 1. doi: 10.1002/ijc.34488.
    PubMed     Abstract available
    
    
    February 2023
30. PAPE M, Kuijper SC, Vissers PAJ, Ruurda JP, et al
    Conditional relative survival in non-metastatic esophagogastric cancer between 2006 and 2020: a population-based study.
    Int J Cancer. 2023 Feb 25. doi: 10.1002/ijc.34480.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Gastric Cancer is free of charge.